Description

In recent years, the abuse of antibiotics has resulted in the mass generation of drug-resistant strains and the increased incidence of fungal infection deep seated in tissues. On the other hand, as the number of patients with immune deficiency increases and people take human organ transplant, interventional treatment and chemotherapeutic agents for tumor, the incidence of fungal infection has gone up gradually, which has boosted the fast growth of anti-fungal drugs.

View Full Report at: http://www.marketresearchreports.biz/analysis/289088

That the incidence of fungal infection has reached 80% in today’s China has driven the rapid growth of anti-fungal drug market. The overall market scale of domestic anti-fungal infection drugs has hit over CNY 5 billion, of which drugs for deep-seated fungal infection take up over 60%.

Voriconazole, a kind of triazole, was developed by Pfizer and came into the US market in 2002. In 2005, voriconazole was introduced into China with Pfizer and its division Upjohn taking up more than 50% of the market. Currently, local firms making voriconazole are Ebang Pharmaceutical, Sichuan Beauty Sport Huakang Pharmaceutical Co., Ltd, Jincheng HEALTH Pharmaceutical Co., Ltd and GeneTech Pharm which occupy the rest Chinese market. According to CRI’s investigation, Voriconazole develops fast after entering China with annual sales rising from CNY 1.14 million in 2005 to CNY 963 million in 2014 and CAGR reaching up to 439.11%.

According to the social epidemiological study, fungal infection is a disease featuring relatively high incidence and reinfection rate. Therefore, anti-fungal drugs enjoy good market prospects.

Download Detail Report With Complete TOC at: http://www.marketresearchreports.biz/sample/sample/289088

Readers can get at least the following information through this report:

market size of voriconazole in China
major manufacturers of voriconazole in Chinese market and their market share
retail price of voriconazole in Chinese market
market outlook of voriconazole in China

The author suggests the following groups of people purchase this report:

manufacturers of anti-fungal drugs
investors/ research institutions interested in Chinese medicine market
any interest in Chinese medicine market, please contact CRI for customized survey service

Table of Content

1 Related Concepts of Voriconazole
1.1 Indication
1.2 Sales Status in Global Market

2 Market Profile of Voriconazole in China
2.1 Patent and Approval Status of Voriconazole in China
2.2 Major Manufacturers
2.3 Market Size

3 Survey on Sales Status of Voriconazole in China, 2010-2014
3.1 Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value by Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume by Regions

Browse all latest Articles of Market Research Reports
at:http://www.marketresearchreports.biz/articles

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save time and money for our clients.
We are a one stop solution for all your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting services. We serve all sizes and types
of companies spanning across various industries.

Browse Our Press Releases by Prnewswire:
http://www.prnewswire.com/news/marketresearchreports.biz

Browse More PressRelease:
http://www.prweb.com/search.aspx?search-releases=marketresearchreports.biz


Contact
Mr. Nachiket
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA: Canada Toll Free: 866-997-4948
Website: http://www.marketresearchreports.biz/
E: [email protected]